Primary endpoint
death, allograft dysfunction
GRAFT LOSS
Difference between the two treatment arms in the proportion of patients with early allograft dysfunction (EAD). EAD (according to Olthoff et al. [Bilirubin level > 10 mg/dL (i.e., 171 μmol/L) on postoperative day (POD) 7INR > 1.6 on POD 7AST or ALT level > 2000 IU/L within the first 7 PODsPrimary non-function (PNF) of the graft is the very last stage of any EAD and is defined by the presence of at least one of the following criteria:Graft loss within the first 7 PODsPatient’s death within the first 7 PODs